Cilostazol labels and packages

Cilostazol
PLETAL® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Studies
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Labels and Packages

PRINCIPAL DISPLAY PANEL - 50mg Bottle Label NDC 59148-003-16

Tablets PLETAL® (cilostazol)

50mg

OTSUKA AMERICA

PHARMACEUTICAL, INC.

60 TABLETS

PRINCIPAL DISPLAY PANEL - 100mg Bottle Label NDC 59148-002-16

Tablets PLETAL® (cilostazol)

100mg

OTSUKA AMERICA

PHARMACEUTICAL, INC.

60 TABLETS

References

Adapted from the FDA Package Insert.